文献速递腹部MR

前瞻性比较扩散加权MRI与动态Gd-EOB-DTPA增强MRI在原发性硬化性胆管炎肝纤维化检测与分期中的价值

Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
PubMed 文献 · Eur Radiol · 2018-07-16

前瞻性纳入47例原发性硬化性胆管炎患者,在3.0T扫描仪上行多参数MRI(含动态Gd-EOB-DTPA增强和扩散加权成像),以瞬时弹性成像肝硬度值为参考标准。ADC与肝硬度显著相关(r=-0.614,p<0.001),且能显著区分F0/1与F2/3及F2/3与F4;Ki虽与肝硬度相关(r=-0.368,p=0.01),但事后两两比较无显著差异(p>0.09)。结论认为DWI对肝纤维化和肝硬化的诊断效能高于Gd-EOB-DTPA增强DCE-MRI。

要点

  • ADC与肝硬度显著相关(r=-0.614,p<0.001),可显著区分F0/1与F2/3及F4(p<0.001)。
  • ADC区分F0/1与F2/3的敏感度/特异度为0.917/0.821,区分F0/1与F4为0.8/0.929。
  • Ki与肝硬度相关(r=-0.368,p=0.01),但事后两两比较无显著差异(p>0.09)。

核心结论

  • 在原发性硬化性胆管炎患者中,DWI对肝纤维化和肝硬化的诊断效能高于Gd-EOB-DTPA增强DCE-MRI。

研究设计与样本

  • 前瞻性研究,纳入47例原发性硬化性胆管炎患者(年龄43.9±14.3岁),在3.0T扫描仪上行多参数MRI,以瞬时弹性成像肝硬度值为参考标准。

关键影像表现/征象

  • ADC与肝硬度呈显著负相关(r=-0.614,p<0.001)。
  • Ki与肝硬度呈显著负相关(r=-0.368,p=0.01)。
  • ADC可显著区分纤维化分期F0/1与F2/3及F4(p<0.001)。
  • Ki对纤维化分期的组间分类有显著主体间效应,但事后两两比较F0/1与F2/3及F4均无显著差异(p>0.096)。

诊断标准与关键数值

  • ADC区分F0/1与F2/3的敏感度/特异度为0.917/0.821。
  • ADC区分F0/1与F4的敏感度/特异度为0.8/0.929。
  • 纤维化分期依据瞬时弹性成像肝硬度值分为F0/F1、F2/3、F4。

临床应用与阅片要点

  • DWI所得ADC可用于区分原发性硬化性胆管炎患者的肝纤维化分期F0/1与F2/3及F4。
  • DCE-MRI所得Ki虽与肝硬度相关,但事后两两比较未能区分各纤维化分期(p>0.09)。
  • LSM、ADC和Ki均与血清肝功能指标、病程及脾脏体积显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the diagnostic value of multiparametric magnetic resonance imaging (MRI) including dynamic Gd-EOB-DTPA-enhanced (DCE) and diffusion-weighted (DW) imaging for diagnosis and staging of hepatic fibrosis in primary sclerosing cholangitis (PSC) using transient elastography as a standard reference.

MATERIAL AND METHODS: Multiparametric MRI was prospectively performed on a 3.0-Tesla scanner in 47 patients (age 43.9±14.3 years). Transient elastography derived liver stiffness measurements (LSM), DCE-MRI derived parameters (hepatocellular uptake rate (Ki), arterial (Fa), portal venous (Fv) and total (Ft) blood flow, mean transit time (MTT), and extracellular volume (Ve)) and the apparent diffusion coefficient (ADC) were calculated. Correlation and univariate analysis of variance with post hoc pairwise comparison were applied to test for differences between LSM derived fibrosis stages (F0/F1, F2/3, F4). ROC curve analysis was used as a performance measure.

RESULTS: Both ADC and Ki correlated significantly with LSM (r= -0.614; p<0.001 and r= -0.368; p=0.01). The ADC significantly discriminated fibrosis stages F0/1 from F2/3 and F4 (p<0.001). Discrimination of F0/1 from F2/3 and F4 reached a sensitivity/specificity of 0.917/0.821 and 0.8/0.929, respectively. Despite significant inter-subject effect for classification of fibrosis stages, post hoc pairwise comparison was not significant for Ki (p>0.096 for F0/1 from F2/3 and F4). LSM, ADC and Ki were significantly associated with serum-based liver functional tests, disease duration and spleen volume.

CONCLUSION: DW-MRI provides a higher diagnostic performance for detection of hepatic fibrosis and cirrhosis in PSC patients in comparison to Gd-EOB-DTPA-enhanced DCE-MRI.

KEY POINTS: • Both ADC and hepatocellular uptake rate (Ki) correlate significantly with liver stiffness (r= -0.614; p<0.001 and r= -0.368; p=0.01). • The DCE-imaging derived quantitative parameter hepatocellular uptake rate (Ki) fails to discriminate pairwise intergroup differences of hepatic fibrosis (p>0.09). • DWI is preferable to DCE-imaging for discrimination of fibrosis stages F0/1 to F2/3 (p<0.001) and F4 (p<0.001).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Keller S, Sedlacik J, Schuler T, et al. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis. Eur Radiol. 2018. PMID: 30014204. doi:10.1007/s00330-018-5614-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。